奥赛康(002755)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002755 奥赛康

已收盘 09-16 15:00:00

{"stockData":{"symbol":"002755","market":"SZ","secType":"STK","nameCN":"奥赛康","latestPrice":11.32,"timestamp":1789542222000,"preClose":11.26,"halted":0,"volume":5370727,"delay":0,"changeRate":0.0053,"floatShares":927999999,"shares":927999999,"eps":0.2126,"marketStatus":"已收盘","change":0.06,"latestTime":"09-16 15:00:00","open":11.26,"high":11.35,"low":11.17,"amount":60551800,"amplitude":0.016,"askPrice":11.33,"askSize":715,"bidPrice":11.32,"bidSize":299,"shortable":0,"etf":0,"ttmEps":0.2126,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789608600000},"marketStatusCode":5,"adr":0,"adjPreClose":11.26,"symbolType":"stock","openAndCloseTimeList":[[1789522200000,1789529400000],[1789534800000,1789542000000]],"highLimit":12.39,"lowLimit":10.13,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":928160351,"isCdr":false,"pbRate":3.24,"roa":"--","peRate":53.245532,"roe":"3.81%","epsLYR":0.25,"committee":-0.19422,"marketValue":10507000000,"turnoverRate":0.0058,"status":0,"floatMarketCap":10507000000},"requestUrl":"/m/hq/s/002755","defaultTab":"news","newsList":[{"id":"2667601058","title":"奥赛康(002755)9月10日股东户数3.33万户，较上期减少4.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667601058","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667601058?lang=zh_cn&edition=full","pubTime":"2026-09-16 17:37","pubTimestamp":1789551450,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2026年9月10日公司股东户数为3.33万户，较8月31日减少1577.0户，减幅为4.52%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至9月10日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年8月31日至2026年9月10日，奥赛康区间涨幅为2.2%，在此期间股东户数减少1577.0户，减幅为4.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600027852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667608241","title":"奥赛康：截至9月10日，公司股东人数为33,305户","url":"https://stock-news.laohu8.com/highlight/detail?id=2667608241","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667608241?lang=zh_cn&edition=full","pubTime":"2026-09-16 15:07","pubTimestamp":1789542441,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康(002755)09月15日在投资者关系平台上答复投资者关心的问题。投资者提问：截止9.10日贵司持股户数有多少？奥赛康回复：您好，截至9月10日，公司股东人数为33,305户，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600018767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666058905","title":"奥赛康(002755)8月31日股东户数3.49万户，较上期增加5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666058905","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666058905?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:28","pubTimestamp":1788946085,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2026年8月31日公司股东户数为3.49万户，较8月20日增加1935.0户，增幅为5.87%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至8月31日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年8月20日至2026年8月31日，奥赛康区间跌幅为18.71%，在此期间股东户数增加1935.0户，增幅为5.87%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900029369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002755","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662244035","title":"股市必读：奥赛康新发布《第七届董事会第九次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662244035","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662244035?lang=zh_cn&edition=full","pubTime":"2026-08-28 05:21","pubTimestamp":1787865675,"startTime":"0","endTime":"0","summary":"股本股东变化：截至2026年8月20日，奥赛康股东户数为3.29万户，较8月10日增长1.12%。公司公告汇总：奥赛康于2026年8月27日召开第七届董事会第九次会议，审议通过《关于公司2026年半年度报告全文及摘要的议案》。股本股东变化股东户数变动截至2026年8月20日，奥赛康股东户数为3.29万户，较8月10日增加364.0户，增幅为1.12%；户均持股数量由2.85万股减少至2.82万股，户均持股市值为39.44万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800009688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662087940","title":"图解奥赛康中报：第二季度单季净利润同比下降65.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662087940","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662087940?lang=zh_cn&edition=full","pubTime":"2026-08-28 02:28","pubTimestamp":1787855296,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康2026年中报显示，上半年度公司主营收入8.71亿元，同比下降13.54%；归母净利润1.21亿元，同比下降24.6%；扣非净利润1.07亿元，同比下降24.44%；其中2026年第二季度，公司单季度主营收入3.89亿元，同比下降21.97%；单季度归母净利润3616.43万元，同比下降65.64%；单季度扣非净利润2960.67万元，同比下降69.47%；负债率24.9%，投资收益266.55万元，财务费用-619.94万元，毛利率82.05%。财报数据概要请见下图:本文数据来源于奥赛康2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800005979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662894630","title":"奥赛康(002755.SZ)发布半年度业绩，归母净利润1.21亿元，同比减少24.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662894630","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662894630?lang=zh_cn&edition=full","pubTime":"2026-08-27 23:16","pubTimestamp":1787843788,"startTime":"0","endTime":"0","summary":"智通财经APP讯，奥赛康 发布2026年半年度报告，报告期内，公司实现营业收入8.71亿元，同比减少13.54%;实现归属于上市公司股东的净利润1.21亿元，同比减少24.6%;实现归属于上市公司股东的扣除非经常性损益的净利润1.07亿元，同比减少24.44%;基本每股收益0.13元。报告期内，公司持续加大对创新药的研发投入，报告期内研发费用较上年同期增加62.58%，导致报告期内公司净利润较上年同期有所减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487560.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"奥赛康(002755.SZ)发布半年度业绩，归母净利润1.21亿元，同比减少24.6%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662779085","title":"奥赛康（002755）披露2026年半年度报告全文及摘要，8月27日股价上涨0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662779085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662779085?lang=zh_cn&edition=full","pubTime":"2026-08-27 22:21","pubTimestamp":1787840476,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，奥赛康报收于12.53元，较前一交易日上涨0.97%，最新总市值为116.3亿元。该股当日开盘12.43元，最高12.63元，最低12.23元，成交额达1.21亿元，换手率为1.05%。近日，北京奥赛康药业股份有限公司召开第七届董事会第九次会议，审议通过《关于公司2026年半年度报告全文及摘要的议案》。会议应到董事9人，实到9人，表决结果为9票同意，0票反对，0票弃权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700055562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662707012","title":"奥赛康披露2026年半年度报告：聚焦临床价值创造 积蓄创新发展势能","url":"https://stock-news.laohu8.com/highlight/detail?id=2662707012","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662707012?lang=zh_cn&edition=full","pubTime":"2026-08-27 20:22","pubTimestamp":1787833340,"startTime":"0","endTime":"0","summary":"8月27日晚间，北京奥赛康药业股份有限公司披露2026年半年度报告。此外，利厄替尼片两项适应症自2026年1月1日起正式执行国家医保目录支付标准。在创新研发方面，奥赛康坚持自主研发与引进合作双向发力，重点聚焦小分子靶向创新药和肿瘤免疫生物创新药。2026年上半年，奥赛康秉持“研究为源，健康为本”的企业理念，以临床价值为导向，统筹推进各项研发与经营工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=aUxwWX1S1qg%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0028","002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662270396","title":"奥赛康(002755)8月20日股东户数3.29万户，较上期增加1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662270396","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662270396?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:10","pubTimestamp":1787825452,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2026年8月20日公司股东户数为3.29万户，较8月10日增加364.0户，增幅为1.12%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至8月20日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年8月10日至2026年8月20日，奥赛康区间涨幅为1.45%，在此期间股东户数增加364.0户，增幅为1.12%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700043420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491972","title":"股市必读：奥赛康(002755)股东户数3.26万户，较上期增加2.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491972","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660491972?lang=zh_cn&edition=full","pubTime":"2026-08-19 02:40","pubTimestamp":1787078425,"startTime":"0","endTime":"0","summary":"截至2026年8月18日收盘，奥赛康报收于13.45元，下跌1.97%，换手率0.9%，成交量8.36万手，成交额1.13亿元。当日关注点交易信息汇总：8月18日主力资金净流出258.45万元，占总成交额2.29%。股本股东变化：截至2026年8月10日，奥赛康股东户数为3.26万户，较7月31日增加797户，增幅2.51%。董秘最新回复投资者： 您好！请问截至8月10日公司股东人数是多少，谢谢董秘： 您好，截至8月10日，公司股东人数为32,583户，感谢您对公司的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900001915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453755","title":"奥赛康：截至8月10日，公司股东人数为32,583户","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453755","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660453755?lang=zh_cn&edition=full","pubTime":"2026-08-18 09:12","pubTimestamp":1787015534,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康(002755)08月18日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！请问截至8月10日公司股东人数是多少，谢谢奥赛康回复：您好，截至8月10日，公司股东人数为32,583户，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800008407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002755","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657597446","title":"股市必读：奥赛康(002755)股东户数3.18万户，较上期增加0.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657597446","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657597446?lang=zh_cn&edition=full","pubTime":"2026-08-07 01:39","pubTimestamp":1786037951,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘，奥赛康报收于13.16元，下跌1.28%，换手率0.84%，成交量7.77万手，成交额1.02亿元。当日关注点交易信息汇总：8月6日主力资金净流入498.19万元，占总成交额4.86%。股本股东变化：截至2026年7月31日，奥赛康股东户数为3.18万户，较7月10日增加34.0户，增幅0.11%。户均持股数量由上期的2.92万股减少至2.92万股，户均持股市值为38.08万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700001723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002755","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657807506","title":"奥赛康：截至7月31日，公司股东人数为31,786户","url":"https://stock-news.laohu8.com/highlight/detail?id=2657807506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657807506?lang=zh_cn&edition=full","pubTime":"2026-08-06 11:37","pubTimestamp":1785987452,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康(002755)08月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止到7月31日公司股东人数是多少？谢谢奥赛康回复：您好，截至7月31日，公司股东人数为31,786户，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600015609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653570409","title":"公司问答丨奥赛康：麦芽酚铁胶囊上市申请于今年3月获受理 目前处于审评阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2653570409","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653570409?lang=zh_cn&edition=full","pubTime":"2026-07-24 15:38","pubTimestamp":1784878689,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","002755","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653703981","title":"奥赛康：利厄替尼片持续推进终端覆盖","url":"https://stock-news.laohu8.com/highlight/detail?id=2653703981","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653703981?lang=zh_cn&edition=full","pubTime":"2026-07-24 11:36","pubTimestamp":1784864167,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康07月23日在投资者关系平台上答复投资者关心的问题。请问目前核心创新药利厄替尼片（奥壹新）在纳入医保后，近期的院内进院和实际销售放量情况如何？马立巴韦片于近期获批，现阶段正在进行各省挂网及生产、销售的各项准备工作。麦芽酚铁胶囊上市申请于今年3月获受理，目前处于审评阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400015879.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652084291","title":"奥赛康(002755)7月10日股东户数3.18万户，较上期减少3.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652084291","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652084291?lang=zh_cn&edition=full","pubTime":"2026-07-20 17:42","pubTimestamp":1784540522,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2026年7月10日公司股东户数为3.18万户，较6月30日减少1135.0户，减幅为3.45%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至7月10日，化学制药行业平均股东户数为3.56万户。从股价来看，2026年6月30日至2026年7月10日，奥赛康区间涨幅为8.3%，在此期间股东户数减少1135.0户，减幅为3.45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000027291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002755","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651445416","title":"奥赛康最新公告：子公司马立巴韦片获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2651445416","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651445416?lang=zh_cn&edition=full","pubTime":"2026-07-16 18:39","pubTimestamp":1784198385,"startTime":"0","endTime":"0","summary":"奥赛康(002755.SZ)公告称，全资子公司江苏奥赛康药业有限公司近日收到国家药监局核准签发的马立巴韦片《药品注册证书》。该药品为全球唯一靶向pUL97蛋白激酶的抗巨细胞病毒上市药物，用于治疗移植后难治性/耐药性CMV感染。此次获批将进一步拓展公司在抗感染领域的管线，增强竞争力。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600032782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651190013","title":"奥赛康(002755)6月30日股东户数3.29万户，较上期减少1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651190013","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651190013?lang=zh_cn&edition=full","pubTime":"2026-07-13 17:51","pubTimestamp":1783936266,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2026年6月30日公司股东户数为3.29万户，较6月20日减少334.0户，减幅为1.01%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.56万户。从股价来看，2026年6月20日至2026年6月30日，奥赛康区间涨幅为6.16%，在此期间股东户数减少334.0户，减幅为1.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300026873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646769588","title":"奥赛康(002755)6月20日股东户数3.32万户，较上期减少1.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646769588","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646769588?lang=zh_cn&edition=full","pubTime":"2026-06-25 17:32","pubTimestamp":1782379938,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2026年6月20日公司股东户数为3.32万户，较6月10日减少592.0户，减幅为1.75%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至6月20日，化学制药行业平均股东户数为3.54万户。从股价来看，2026年6月10日至2026年6月20日，奥赛康区间跌幅为0.29%，在此期间股东户数减少592.0户，减幅为1.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500031884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646840133","title":"奥赛康：截至6月20日，公司股东人数为33,221户","url":"https://stock-news.laohu8.com/highlight/detail?id=2646840133","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646840133?lang=zh_cn&edition=full","pubTime":"2026-06-25 09:15","pubTimestamp":1782350110,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康(002755)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：截止6月20日，公司股东人数为多少？奥赛康回复：您好，截至6月20日，公司股东人数为33,221户，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500007900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002755","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789572058040,"stockEarnings":[{"period":"1week","weight":-0.074},{"period":"1month","weight":-0.1805},{"period":"3month","weight":-0.1063},{"period":"6month","weight":-0.2382},{"period":"1year","weight":-0.4864},{"period":"ytd","weight":-0.3039}],"compareEarnings":[{"period":"1week","weight":-0.0194},{"period":"1month","weight":-0.016},{"period":"3month","weight":-0.0593},{"period":"6month","weight":-0.0355},{"period":"1year","weight":0.001},{"period":"ytd","weight":-0.0263}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京奥赛康药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"33305人(较上一季度减少4.52%)","perCapita":"27868股","listingDate":"2015-05-15","address":"北京市丰台区南四环西路188号七区28号楼","registeredCapital":"92816万元","survey":"　　北京奥赛康药业股份有限公司的主营业务是原料药及制剂的研发、生产、销售。公司的主要产品是消化类、抗肿瘤类、抗感染类、慢性病类。公司11件主导产品核心专利技术分别荣获中国专利金奖1项、省专利项目奖金奖1项、省专利项目奖优秀奖3项、市优秀专利奖6项。","listedPrice":7.49},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥赛康(002755)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥赛康(002755)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥赛康,002755,奥赛康股票,奥赛康股票老虎,奥赛康股票老虎国际,奥赛康行情,奥赛康股票行情,奥赛康股价,奥赛康股市,奥赛康股票价格,奥赛康股票交易,奥赛康股票购买,奥赛康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥赛康(002755)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥赛康(002755)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}